Mestag Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Mestag Therapeutics's estimated annual revenue is currently $10.5M per year.
- Mestag Therapeutics's estimated revenue per employee is $155,000
- Mestag Therapeutics's total funding is $45M.
Employee Data
- Mestag Therapeutics has 68 Employees.
- Mestag Therapeutics grew their employee count by 13% last year.
Mestag Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Medical Officer (cons) | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Medical Officer | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | SVP, Head Development | Reveal Email/Phone |
6 | Lead Assay Scientist and Biological Safety Officer | Reveal Email/Phone |
7 | Director, Head Biology | Reveal Email/Phone |
8 | Associate Director, Head People | Reveal Email/Phone |
9 | Executive Assistant and Office Manager | Reveal Email/Phone |
10 | Office Manager | Reveal Email/Phone |
Mestag Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 35 | -12% | N/A | N/A |
#2 | $16.3M | 105 | 4% | N/A | N/A |
#3 | $107.2M | 494 | 25% | $292M | N/A |
#4 | $2.6M | 830 | 30% | $631.7M | N/A |
#5 | $18.1M | 117 | -8% | $81M | N/A |
#6 | $54.6M | 282 | 0% | $132.9M | N/A |
#7 | $9.3M | 60 | -37% | N/A | N/A |
#8 | $21.2M | 137 | 12% | N/A | N/A |
#9 | $408.2M | 1646 | 11% | £994.6M | N/A |
#10 | $963.5M | 6216 | 12% | N/A | N/A |
What Is Mestag Therapeutics?
Mestag Therapeutics is a fast-moving, stealth mode biotech, newly formed to explore emerging understanding of fibroblast subpopulations as targetable drivers of disease. Our goal is to bring transformative therapies to enriched patient populations with enduring unmet needs in inflammatory disease and oncology. Mestag Therapeutics' founders are world leaders in fibroblast biology and severe diseases. We are actively assembling a driven, motivated team to explore new therapeutic opportunities. Backed by SV Health Investors, a leading life sciences & healthcare investor with over $3 billion in capital commitments, Mestag has raised capital from the Impact Medicine Fund, which invests in precision medicine therapeutics in areas of high unmet need. We are hiring! Reach out to learn more about opportunities to join our team.
keywords:N/A$45M
Total Funding
68
Number of Employees
$10.5M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mestag Therapeutics News
Mestag Therapeutics, a breakthrough inflammatory disease and immuno-oncology company based in Cambridge, has appointed a life science...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.3M | 68 | 24% | N/A |
#2 | $8.9M | 68 | -8% | $2M |
#3 | $7.5M | 68 | 17% | N/A |
#4 | $16.5M | 68 | -17% | N/A |
#5 | $7.3M | 68 | 10% | N/A |